The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that can come with an array of unpleasant side effects. However, a new drug ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.